Global Prescription Digital Therapeutics (Pdt) Market Research Report 2025(Status and Outlook)

October 2025 | 132 pages | ID: GADC1D03F755EN
Bosson Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Overview

Prescription digital therapeutics is a form of software-based therapeutics used to treat a wide range of illnesses. Technology and biology are combined to make prescription digital medications. These therapeutic tools were created using artificial intelligence, several algorithms, and virtual reality. Prescription PDTs, or digital therapeutics, are a brand-new medicinal category. PDTs act as direct treatments for critical disorders such as conventional biologics or medications.

The global Prescription Digital Therapeutics (Pdt) market size was estimated at USD 4035.25 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 21.40% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Prescription Digital Therapeutics (Pdt) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Prescription Digital Therapeutics (Pdt) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Prescription Digital Therapeutics (Pdt) market

Global Prescription Digital Therapeutics (Pdt) Market: Market Segmentation Analysis


This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

Akili Interactive
Pear Therapeutics
Better Therapeutics
ResMed
Biofourmis
Novartis
Medtronic
Voluntis
Omada Health
GAIA
Solera Network
BigHealth
Click Therapeutics
Happify
Limbix Health
Naturalcycles Nordic
NuvoAir
Sensyne Health
Xealth

Market Segmentation (by Type)

Medication Augmentation
Medication Replacement

Market Segmentation (by Application)

Children
Adults

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Prescription Digital Therapeutics (Pdt) Market
  • Overview of the regional outlook of the Prescription Digital Therapeutics (Pdt) Market.
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Prescription Digital Therapeutics (Pdt) Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Prescription Digital Therapeutics (Pdt), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Prescription Digital Therapeutics (Pdt)
1.2 Key Market Segments
  1.2.1 Prescription Digital Therapeutics (Pdt) Segment by Type
  1.2.2 Prescription Digital Therapeutics (Pdt) Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 PRESCRIPTION DIGITAL THERAPEUTICS (PDT) MARKET OVERVIEW

2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 PRESCRIPTION DIGITAL THERAPEUTICS (PDT) MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Prescription Digital Therapeutics (Pdt) Product Life Cycle
3.3 Global Prescription Digital Therapeutics (Pdt) Revenue Market Share by Company (2020-2025)
3.4 Prescription Digital Therapeutics (Pdt) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Prescription Digital Therapeutics (Pdt) Company Headquarters, Area Served, Product Type
3.6 Prescription Digital Therapeutics (Pdt) Market Competitive Situation and Trends
  3.6.1 Prescription Digital Therapeutics (Pdt) Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Prescription Digital Therapeutics (Pdt) Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 PRESCRIPTION DIGITAL THERAPEUTICS (PDT) VALUE CHAIN ANALYSIS

4.1 Prescription Digital Therapeutics (Pdt) Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF PRESCRIPTION DIGITAL THERAPEUTICS (PDT) MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Prescription Digital Therapeutics (Pdt) Market Porter's Five Forces Analysis

6 PRESCRIPTION DIGITAL THERAPEUTICS (PDT) MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Prescription Digital Therapeutics (Pdt) Market Size Market Share by Type (2020-2025)
6.3 Global Prescription Digital Therapeutics (Pdt) Market Size Growth Rate by Type (2021-2025)

7 PRESCRIPTION DIGITAL THERAPEUTICS (PDT) MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Prescription Digital Therapeutics (Pdt) Market Size (M USD) by Application (2020-2025)
7.3 Global Prescription Digital Therapeutics (Pdt) Sales Growth Rate by Application (2020-2025)

8 PRESCRIPTION DIGITAL THERAPEUTICS (PDT) MARKET SEGMENTATION BY REGION

8.1 Global Prescription Digital Therapeutics (Pdt) Market Size by Region
  8.1.1 Global Prescription Digital Therapeutics (Pdt) Market Size by Region
  8.1.2 Global Prescription Digital Therapeutics (Pdt) Market Size Market Share by Region
8.2 North America
  8.2.1 North America Prescription Digital Therapeutics (Pdt) Market Size by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Prescription Digital Therapeutics (Pdt) Market Size by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Spain
8.4 Asia Pacific
  8.4.1 Asia Pacific Prescription Digital Therapeutics (Pdt) Market Size by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Prescription Digital Therapeutics (Pdt) Market Size by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Prescription Digital Therapeutics (Pdt) Market Size by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 Akili Interactive
  9.1.1 Akili Interactive Basic Information
  9.1.2 Akili Interactive Prescription Digital Therapeutics (Pdt) Product Overview
  9.1.3 Akili Interactive Prescription Digital Therapeutics (Pdt) Product Market Performance
  9.1.4 Akili Interactive SWOT Analysis
  9.1.5 Akili Interactive Business Overview
  9.1.6 Akili Interactive Recent Developments
9.2 Pear Therapeutics
  9.2.1 Pear Therapeutics Basic Information
  9.2.2 Pear Therapeutics Prescription Digital Therapeutics (Pdt) Product Overview
  9.2.3 Pear Therapeutics Prescription Digital Therapeutics (Pdt) Product Market Performance
  9.2.4 Pear Therapeutics SWOT Analysis
  9.2.5 Pear Therapeutics Business Overview
  9.2.6 Pear Therapeutics Recent Developments
9.3 Better Therapeutics
  9.3.1 Better Therapeutics Basic Information
  9.3.2 Better Therapeutics Prescription Digital Therapeutics (Pdt) Product Overview
  9.3.3 Better Therapeutics Prescription Digital Therapeutics (Pdt) Product Market Performance
  9.3.4 Better Therapeutics SWOT Analysis
  9.3.5 Better Therapeutics Business Overview
  9.3.6 Better Therapeutics Recent Developments
9.4 ResMed
  9.4.1 ResMed Basic Information
  9.4.2 ResMed Prescription Digital Therapeutics (Pdt) Product Overview
  9.4.3 ResMed Prescription Digital Therapeutics (Pdt) Product Market Performance
  9.4.4 ResMed Business Overview
  9.4.5 ResMed Recent Developments
9.5 Biofourmis
  9.5.1 Biofourmis Basic Information
  9.5.2 Biofourmis Prescription Digital Therapeutics (Pdt) Product Overview
  9.5.3 Biofourmis Prescription Digital Therapeutics (Pdt) Product Market Performance
  9.5.4 Biofourmis Business Overview
  9.5.5 Biofourmis Recent Developments
9.6 Novartis
  9.6.1 Novartis Basic Information
  9.6.2 Novartis Prescription Digital Therapeutics (Pdt) Product Overview
  9.6.3 Novartis Prescription Digital Therapeutics (Pdt) Product Market Performance
  9.6.4 Novartis Business Overview
  9.6.5 Novartis Recent Developments
9.7 Medtronic
  9.7.1 Medtronic Basic Information
  9.7.2 Medtronic Prescription Digital Therapeutics (Pdt) Product Overview
  9.7.3 Medtronic Prescription Digital Therapeutics (Pdt) Product Market Performance
  9.7.4 Medtronic Business Overview
  9.7.5 Medtronic Recent Developments
9.8 Voluntis
  9.8.1 Voluntis Basic Information
  9.8.2 Voluntis Prescription Digital Therapeutics (Pdt) Product Overview
  9.8.3 Voluntis Prescription Digital Therapeutics (Pdt) Product Market Performance
  9.8.4 Voluntis Business Overview
  9.8.5 Voluntis Recent Developments
9.9 Omada Health
  9.9.1 Omada Health Basic Information
  9.9.2 Omada Health Prescription Digital Therapeutics (Pdt) Product Overview
  9.9.3 Omada Health Prescription Digital Therapeutics (Pdt) Product Market Performance
  9.9.4 Omada Health Business Overview
  9.9.5 Omada Health Recent Developments
9.10 GAIA
  9.10.1 GAIA Basic Information
  9.10.2 GAIA Prescription Digital Therapeutics (Pdt) Product Overview
  9.10.3 GAIA Prescription Digital Therapeutics (Pdt) Product Market Performance
  9.10.4 GAIA Business Overview
  9.10.5 GAIA Recent Developments
9.11 Solera Network
  9.11.1 Solera Network Basic Information
  9.11.2 Solera Network Prescription Digital Therapeutics (Pdt) Product Overview
  9.11.3 Solera Network Prescription Digital Therapeutics (Pdt) Product Market Performance
  9.11.4 Solera Network Business Overview
  9.11.5 Solera Network Recent Developments
9.12 BigHealth
  9.12.1 BigHealth Basic Information
  9.12.2 BigHealth Prescription Digital Therapeutics (Pdt) Product Overview
  9.12.3 BigHealth Prescription Digital Therapeutics (Pdt) Product Market Performance
  9.12.4 BigHealth Business Overview
  9.12.5 BigHealth Recent Developments
9.13 Click Therapeutics
  9.13.1 Click Therapeutics Basic Information
  9.13.2 Click Therapeutics Prescription Digital Therapeutics (Pdt) Product Overview
  9.13.3 Click Therapeutics Prescription Digital Therapeutics (Pdt) Product Market Performance
  9.13.4 Click Therapeutics Business Overview
  9.13.5 Click Therapeutics Recent Developments
9.14 Happify
  9.14.1 Happify Basic Information
  9.14.2 Happify Prescription Digital Therapeutics (Pdt) Product Overview
  9.14.3 Happify Prescription Digital Therapeutics (Pdt) Product Market Performance
  9.14.4 Happify Business Overview
  9.14.5 Happify Recent Developments
9.15 Limbix Health
  9.15.1 Limbix Health Basic Information
  9.15.2 Limbix Health Prescription Digital Therapeutics (Pdt) Product Overview
  9.15.3 Limbix Health Prescription Digital Therapeutics (Pdt) Product Market Performance
  9.15.4 Limbix Health Business Overview
  9.15.5 Limbix Health Recent Developments
9.16 Naturalcycles Nordic
  9.16.1 Naturalcycles Nordic Basic Information
  9.16.2 Naturalcycles Nordic Prescription Digital Therapeutics (Pdt) Product Overview
  9.16.3 Naturalcycles Nordic Prescription Digital Therapeutics (Pdt) Product Market Performance
  9.16.4 Naturalcycles Nordic Business Overview
  9.16.5 Naturalcycles Nordic Recent Developments
9.17 NuvoAir
  9.17.1 NuvoAir Basic Information
  9.17.2 NuvoAir Prescription Digital Therapeutics (Pdt) Product Overview
  9.17.3 NuvoAir Prescription Digital Therapeutics (Pdt) Product Market Performance
  9.17.4 NuvoAir Business Overview
  9.17.5 NuvoAir Recent Developments
9.18 Sensyne Health
  9.18.1 Sensyne Health Basic Information
  9.18.2 Sensyne Health Prescription Digital Therapeutics (Pdt) Product Overview
  9.18.3 Sensyne Health Prescription Digital Therapeutics (Pdt) Product Market Performance
  9.18.4 Sensyne Health Business Overview
  9.18.5 Sensyne Health Recent Developments
9.19 Xealth
  9.19.1 Xealth Basic Information
  9.19.2 Xealth Prescription Digital Therapeutics (Pdt) Product Overview
  9.19.3 Xealth Prescription Digital Therapeutics (Pdt) Product Market Performance
  9.19.4 Xealth Business Overview
  9.19.5 Xealth Recent Developments

10 PRESCRIPTION DIGITAL THERAPEUTICS (PDT) MARKET FORECAST BY REGION

10.1 Global Prescription Digital Therapeutics (Pdt) Market Size Forecast
10.2 Global Prescription Digital Therapeutics (Pdt) Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Prescription Digital Therapeutics (Pdt) Market Size Forecast by Country
  10.2.3 Asia Pacific Prescription Digital Therapeutics (Pdt) Market Size Forecast by Region
  10.2.4 South America Prescription Digital Therapeutics (Pdt) Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Sales of Prescription Digital Therapeutics (Pdt) by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)

11.1 Global Prescription Digital Therapeutics (Pdt) Market Forecast by Type (2026-2033)
11.2 Global Prescription Digital Therapeutics (Pdt) Market Forecast by Application (2026-2033)

12 CONCLUSION AND KEY FINDINGS


LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Prescription Digital Therapeutics (Pdt) Market Size Comparison by Region (M USD)
Table 5. Global Prescription Digital Therapeutics (Pdt) Revenue (M USD) by Company (2020-2025)
Table 6. Global Prescription Digital Therapeutics (Pdt) Revenue Share by Company (2020-2025)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Digital Therapeutics (Pdt) as of 2024)
Table 8. Prescription Digital Therapeutics (Pdt) Company Headquarters and Area Served
Table 9. Company Prescription Digital Therapeutics (Pdt) Product Type
Table 10. Global Prescription Digital Therapeutics (Pdt) Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Midstream Market Analysis
Table 13. Downstream Customer Analysis
Table 14. Key Development Trends
Table 15. Driving Factors
Table 16. Prescription Digital Therapeutics (Pdt) Market Challenges
Table 17. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 18. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 19. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 20. Global Prescription Digital Therapeutics (Pdt) Market Size by Type (M USD)
Table 21. Global Prescription Digital Therapeutics (Pdt) Market Size (M USD) by Type (2020-2025)
Table 22. Global Prescription Digital Therapeutics (Pdt) Market Size Share by Type (2020-2025)
Table 23. Global Prescription Digital Therapeutics (Pdt) Market Size Growth Rate by Type (2021-2025)
Table 24. Global Prescription Digital Therapeutics (Pdt) Market Size by Application
Table 25. Global Prescription Digital Therapeutics (Pdt) Market Size by Application (2020-2025) & (M USD)
Table 26. Global Prescription Digital Therapeutics (Pdt) Market Share by Application (2020-2025)
Table 27. Global Prescription Digital Therapeutics (Pdt) Sales Growth Rate by Application (2020-2025)
Table 28. Global Prescription Digital Therapeutics (Pdt) Market Size by Region (2020-2025) & (M USD)
Table 29. Global Prescription Digital Therapeutics (Pdt) Market Size Market Share by Region (2020-2025)
Table 30. North America Prescription Digital Therapeutics (Pdt) Market Size by Country (2020-2025) & (M USD)
Table 31. Europe Prescription Digital Therapeutics (Pdt) Market Size by Country (2020-2025) & (M USD)
Table 32. Asia Pacific Prescription Digital Therapeutics (Pdt) Market Size by Region (2020-2025) & (M USD)
Table 33. South America Prescription Digital Therapeutics (Pdt) Market Size by Country (2020-2025) & (M USD)
Table 34. Middle East and Africa Prescription Digital Therapeutics (Pdt) Market Size by Region (2020-2025) & (M USD)
Table 35. Akili Interactive Basic Information
Table 36. Akili Interactive Prescription Digital Therapeutics (Pdt) Product Overview
Table 37. Akili Interactive Prescription Digital Therapeutics (Pdt) Revenue (M USD) and Gross Margin (2020-2025)
Table 38. Akili Interactive SWOT Analysis
Table 39. Akili Interactive Business Overview
Table 40. Akili Interactive Recent Developments
Table 41. Pear Therapeutics Basic Information
Table 42. Pear Therapeutics Prescription Digital Therapeutics (Pdt) Product Overview
Table 43. Pear Therapeutics Prescription Digital Therapeutics (Pdt) Revenue (M USD) and Gross Margin (2020-2025)
Table 44. Pear Therapeutics SWOT Analysis
Table 45. Pear Therapeutics Business Overview
Table 46. Pear Therapeutics Recent Developments
Table 47. Better Therapeutics Basic Information
Table 48. Better Therapeutics Prescription Digital Therapeutics (Pdt) Product Overview
Table 49. Better Therapeutics Prescription Digital Therapeutics (Pdt) Revenue (M USD) and Gross Margin (2020-2025)
Table 50. Better Therapeutics SWOT Analysis
Table 51. Better Therapeutics Business Overview
Table 52. Better Therapeutics Recent Developments
Table 53. ResMed Basic Information
Table 54. ResMed Prescription Digital Therapeutics (Pdt) Product Overview
Table 55. ResMed Prescription Digital Therapeutics (Pdt) Revenue (M USD) and Gross Margin (2020-2025)
Table 56. ResMed Business Overview
Table 57. ResMed Recent Developments
Table 58. Biofourmis Basic Information
Table 59. Biofourmis Prescription Digital Therapeutics (Pdt) Product Overview
Table 60. Biofourmis Prescription Digital Therapeutics (Pdt) Revenue (M USD) and Gross Margin (2020-2025)
Table 61. Biofourmis Business Overview
Table 62. Biofourmis Recent Developments
Table 63. Novartis Basic Information
Table 64. Novartis Prescription Digital Therapeutics (Pdt) Product Overview
Table 65. Novartis Prescription Digital Therapeutics (Pdt) Revenue (M USD) and Gross Margin (2020-2025)
Table 66. Novartis Business Overview
Table 67. Novartis Recent Developments
Table 68. Medtronic Basic Information
Table 69. Medtronic Prescription Digital Therapeutics (Pdt) Product Overview
Table 70. Medtronic Prescription Digital Therapeutics (Pdt) Revenue (M USD) and Gross Margin (2020-2025)
Table 71. Medtronic Business Overview
Table 72. Medtronic Recent Developments
Table 73. Voluntis Basic Information
Table 74. Voluntis Prescription Digital Therapeutics (Pdt) Product Overview
Table 75. Voluntis Prescription Digital Therapeutics (Pdt) Revenue (M USD) and Gross Margin (2020-2025)
Table 76. Voluntis Business Overview
Table 77. Voluntis Recent Developments
Table 78. Omada Health Basic Information
Table 79. Omada Health Prescription Digital Therapeutics (Pdt) Product Overview
Table 80. Omada Health Prescription Digital Therapeutics (Pdt) Revenue (M USD) and Gross Margin (2020-2025)
Table 81. Omada Health Business Overview
Table 82. Omada Health Recent Developments
Table 83. GAIA Basic Information
Table 84. GAIA Prescription Digital Therapeutics (Pdt) Product Overview
Table 85. GAIA Prescription Digital Therapeutics (Pdt) Revenue (M USD) and Gross Margin (2020-2025)
Table 86. GAIA Business Overview
Table 87. GAIA Recent Developments
Table 88. Solera Network Basic Information
Table 89. Solera Network Prescription Digital Therapeutics (Pdt) Product Overview
Table 90. Solera Network Prescription Digital Therapeutics (Pdt) Revenue (M USD) and Gross Margin (2020-2025)
Table 91. Solera Network Business Overview
Table 92. Solera Network Recent Developments
Table 93. BigHealth Basic Information
Table 94. BigHealth Prescription Digital Therapeutics (Pdt) Product Overview
Table 95. BigHealth Prescription Digital Therapeutics (Pdt) Revenue (M USD) and Gross Margin (2020-2025)
Table 96. BigHealth Business Overview
Table 97. BigHealth Recent Developments
Table 98. Click Therapeutics Basic Information
Table 99. Click Therapeutics Prescription Digital Therapeutics (Pdt) Product Overview
Table 100. Click Therapeutics Prescription Digital Therapeutics (Pdt) Revenue (M USD) and Gross Margin (2020-2025)
Table 101. Click Therapeutics Business Overview
Table 102. Click Therapeutics Recent Developments
Table 103. Happify Basic Information
Table 104. Happify Prescription Digital Therapeutics (Pdt) Product Overview
Table 105. Happify Prescription Digital Therapeutics (Pdt) Revenue (M USD) and Gross Margin (2020-2025)
Table 106. Happify Business Overview
Table 107. Happify Recent Developments
Table 108. Limbix Health Basic Information
Table 109. Limbix Health Prescription Digital Therapeutics (Pdt) Product Overview
Table 110. Limbix Health Prescription Digital Therapeutics (Pdt) Revenue (M USD) and Gross Margin (2020-2025)
Table 111. Limbix Health Business Overview
Table 112. Limbix Health Recent Developments
Table 113. Naturalcycles Nordic Basic Information
Table 114. Naturalcycles Nordic Prescription Digital Therapeutics (Pdt) Product Overview
Table 115. Naturalcycles Nordic Prescription Digital Therapeutics (Pdt) Revenue (M USD) and Gross Margin (2020-2025)
Table 116. Naturalcycles Nordic Business Overview
Table 117. Naturalcycles Nordic Recent Developments
Table 118. NuvoAir Basic Information
Table 119. NuvoAir Prescription Digital Therapeutics (Pdt) Product Overview
Table 120. NuvoAir Prescription Digital Therapeutics (Pdt) Revenue (M USD) and Gross Margin (2020-2025)
Table 121. NuvoAir Business Overview
Table 122. NuvoAir Recent Developments
Table 123. Sensyne Health Basic Information
Table 124. Sensyne Health Prescription Digital Therapeutics (Pdt) Product Overview
Table 125. Sensyne Health Prescription Digital Therapeutics (Pdt) Revenue (M USD) and Gross Margin (2020-2025)
Table 126. Sensyne Health Business Overview
Table 127. Sensyne Health Recent Developments
Table 128. Xealth Basic Information
Table 129. Xealth Prescription Digital Therapeutics (Pdt) Product Overview
Table 130. Xealth Prescription Digital Therapeutics (Pdt) Revenue (M USD) and Gross Margin (2020-2025)
Table 131. Xealth Business Overview
Table 132. Xealth Recent Developments
Table 133. Global Prescription Digital Therapeutics (Pdt) Market Size Forecast by Region (2026-2033) & (M USD)
Table 134. North America Prescription Digital Therapeutics (Pdt) Market Size Forecast by Country (2026-2033) & (M USD)
Table 135. Europe Prescription Digital Therapeutics (Pdt) Market Size Forecast by Country (2026-2033) & (M USD)
Table 136. Asia Pacific Prescription Digital Therapeutics (Pdt) Market Size Forecast by Region (2026-2033) & (M USD)
Table 137. South America Prescription Digital Therapeutics (Pdt) Market Size Forecast by Country (2026-2033) & (M USD)
Table 138. Middle East and Africa Prescription Digital Therapeutics (Pdt) Market Size Forecast by Country (2026-2033) & (M USD)
Table 139. Global Prescription Digital Therapeutics (Pdt) Market Size Forecast by Type (2026-2033) & (M USD)
Table 140. Global Prescription Digital Therapeutics (Pdt) Market Size Forecast by Application (2026-2033) & (M USD)

LIST OF FIGURES

Figure 1. Industry Chain of Prescription Digital Therapeutics (Pdt)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Prescription Digital Therapeutics (Pdt) Market Size (M USD), 2024-2033
Figure 5. Global Prescription Digital Therapeutics (Pdt) Market Size (M USD) (2020-2033)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Prescription Digital Therapeutics (Pdt) Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Prescription Digital Therapeutics (Pdt) Product Life Cycle
Figure 12. Global Prescription Digital Therapeutics (Pdt) Revenue Share by Company in 2024
Figure 13. Prescription Digital Therapeutics (Pdt) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 14. The Global 5 and 10 Largest Players: Market Share by Prescription Digital Therapeutics (Pdt) Revenue in 2024
Figure 15. Value Chain Map of Prescription Digital Therapeutics (Pdt)
Figure 16. Global Prescription Digital Therapeutics (Pdt) Market PEST Analysis
Figure 17. Global Prescription Digital Therapeutics (Pdt) Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Prescription Digital Therapeutics (Pdt) Market Share by Type
Figure 20. Market Size Share of Prescription Digital Therapeutics (Pdt) by Type (2020-2025)
Figure 21. Market Size Share of Prescription Digital Therapeutics (Pdt) by Type in 2024
Figure 22. Global Prescription Digital Therapeutics (Pdt) Market Size Growth Rate by Type (2021-2025)
Figure 23. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 24. Global Prescription Digital Therapeutics (Pdt) Market Share by Application
Figure 25. Global Prescription Digital Therapeutics (Pdt) Market Share by Application (2020-2025)
Figure 26. Global Prescription Digital Therapeutics (Pdt) Market Share by Application in 2024
Figure 27. Global Prescription Digital Therapeutics (Pdt) Sales Growth Rate by Application (2020-2025)
Figure 28. Global Prescription Digital Therapeutics (Pdt) Market Size Market Share by Region (2020-2025)
Figure 29. North America Prescription Digital Therapeutics (Pdt) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 30. North America Prescription Digital Therapeutics (Pdt) Market Size Market Share by Country in 2024
Figure 31. U.S. Prescription Digital Therapeutics (Pdt) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 32. Canada Prescription Digital Therapeutics (Pdt) Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Mexico Prescription Digital Therapeutics (Pdt) Market Size (M USD) and Growth Rate (2020-2025)
Figure 34. Europe Prescription Digital Therapeutics (Pdt) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 35. Europe Prescription Digital Therapeutics (Pdt) Market Share by Country in 2024
Figure 36. Germany Prescription Digital Therapeutics (Pdt) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. France Prescription Digital Therapeutics (Pdt) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. U.K. Prescription Digital Therapeutics (Pdt) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Italy Prescription Digital Therapeutics (Pdt) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Spain Prescription Digital Therapeutics (Pdt) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 41. Asia Pacific Prescription Digital Therapeutics (Pdt) Market Size and Growth Rate (M USD)
Figure 42. Asia Pacific Prescription Digital Therapeutics (Pdt) Market Size Market Share by Region in 2024
Figure 43. China Prescription Digital Therapeutics (Pdt) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. Japan Prescription Digital Therapeutics (Pdt) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. South Korea Prescription Digital Therapeutics (Pdt) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. India Prescription Digital Therapeutics (Pdt) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Southeast Asia Prescription Digital Therapeutics (Pdt) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 48. South America Prescription Digital Therapeutics (Pdt) Market Size and Growth Rate (M USD)
Figure 49. South America Prescription Digital Therapeutics (Pdt) Market Size Market Share by Country in 2024
Figure 50. Brazil Prescription Digital Therapeutics (Pdt) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Argentina Prescription Digital Therapeutics (Pdt) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Columbia Prescription Digital Therapeutics (Pdt) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 53. Middle East and Africa Prescription Digital Therapeutics (Pdt) Market Size and Growth Rate (M USD)
Figure 54. Middle East and Africa Prescription Digital Therapeutics (Pdt) Market Size Market Share by Region in 2024
Figure 55. Saudi Arabia Prescription Digital Therapeutics (Pdt) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. UAE Prescription Digital Therapeutics (Pdt) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Egypt Prescription Digital Therapeutics (Pdt) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. Nigeria Prescription Digital Therapeutics (Pdt) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. South Africa Prescription Digital Therapeutics (Pdt) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Global Prescription Digital Therapeutics (Pdt) Market Size Forecast (2020-2033) & (M USD)
Figure 61. Global Prescription Digital Therapeutics (Pdt) Market Share Forecast by Type (2026-2033)
Figure 62. Global Prescription Digital Therapeutics (Pdt) Market Share Forecast by Application (2026-2033)


More Publications